Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB-Reference-Cited by-同舟云学术

Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB

Published:2020-09-12 Issue:6 Volume:17 Page:589-600
ISSN:1548-3568
Container-title:Current HIV/AIDS Reports
language:en
Short-container-title:Curr HIV/AIDS Rep

Author:

Ignatius Elisa H.,Swindells Susan^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Virology

Link

https://link.springer.com/content/pdf/10.1007/s11904-020-00529-8.pdf

Reference102 articles.

1. • World Health Organization (WHO). Global Tuberculosis Report 2019. World Health Organization; 2019. Current data on the state of the global TB epidemic.

2. Séraphin MN, Hsu H, Chapman HJ, de Andrade Bezerra JL, Johnston L, Yang Y, et al. Timing of treatment interruption among latently infected tuberculosis cases treated with a nine-month course of daily isoniazid: findings from a time to event analysis. BMC Public Health. 2019;19(1):1214. https://doi.org/10.1186/s12889-019-7524-4.

3. Clinical Pipeline. Working Group on New TB Drugs. https://www.newtbdrugs.org/pipeline/clinical. .

4. Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13(10):e1002152. https://doi.org/10.1371/journal.pmed.1002152.

5. Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1999;340(5):367–73. https://doi.org/10.1056/NEJM199902043400507.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV–TB Coinfection: Current Therapeutic Approaches and Drug Interactions;Viruses;2024-02-21

2. Viral–bacterial interactions within hosts;Molecular Medical Microbiology;2024

3. Multiomics technologies applied to tuberculosis drug discovery;Biological Insights of Multi-Omics Technologies in Human Diseases;2024

4. Evaluation of the IP-10 mRNA release assay for diagnosis of TB in HIV-infected individuals;Frontiers in Cellular and Infection Microbiology;2023-06-02

5. High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus;Antimicrobial Agents and Chemotherapy;2023-02-16